A

Active Director Director DIN 09099207
DIN 09099207 First appointment Mar 2021 Primary industry Research & Development
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Asha

Data last updated:

Asha is a Director at Iyibio Lifesciences Private Limited (since 2021). The company operates in Research & Development. Iyibio Lifesciences Private Limited reported revenue of ₹96 Lakh (FY 2025).

DIN 09099207
Primary Designation Director
Industry Research & Development
First Appointment 09 Mar 2021
Oldest Company Age 5 yrs
Largest company Iyibio Lifesciences Private Limited · ₹96 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Iyibio Lifesciences Private Limited U73100DL2021PTC378208
Director09 Mar 20212021₹96 Lakh (FY 2025)Active

Board colleagues of Asha

NameDINCompanyDesignation
Arvind Kumar09099208Iyibio Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Iyibio Lifesciences Private Limited
Premium access

Shareholding and investment profile for Asha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Asha

Asha currently holds 1 directorship: Iyibio Lifesciences Private Limited (Director, since 09 Mar 2021, revenue ₹96 Lakh (FY 2025)).

Asha was first appointed on 09 Mar 2021 as Director at Iyibio Lifesciences Private Limited.

The current boards of Asha's companies include Arvind Kumar (Iyibio Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available